Telix Pharmaceuticals
TLX · NASDAQ
TLX key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 401.19K
- Volume
- 413.45K
- Open price
- $9.26
- High today
- $9.30
- Low today
- $9.11
- 52 Week high
- $13.11
- 52 Week low
- $6.28
Telix Pharmaceuticals (TLX) at a glance
As of Oct 23, 2026, Telix Pharmaceuticals (TLX) shares are priced at $9.15, giving the company a price-to-earnings ratio of 0.00.
Today the stock has traded between $9.11 and $9.30. The current price is 0.4% above the day's low and 1.6% below its high.
Volume so far is 413.45K shares, in line with the average of 401.19K shares a day.
Over the past year Telix Pharmaceuticals has ranged from $6.28 to $13.11, and now sits 42% of the way up that range.
The average analyst price target is $0.00, 100.0% below the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $0.00
- Now
- $9.15
- High
- $0.00
TLX news
- Avi Kapoor
Telix Receives FDA's Fast Track Designation For Its BiPASS Program To Trace Prostate Cancer Prior To Biopsy
- Avi Kapoor
Crude Oil Down 4%; Intel Shares Move Higher
- Vandana Singh
Telix Makes $1.65 Billion Bet on ITM to Build a Radiopharma Powerhouse
Reported September 20, 2026: 'Australia's Telix Pharma Agrees To Buy Germany's ITM Isotope For About $1.65B'
- Vandana Singh
FDA Approves Telix Pharmaceuticals Brain Cancer Imaging Drug
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releaseGlobe Newswire
Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.